Adaptive and innate immunity utilize the perforin-killing pathway to eliminate virus-infected or cancer cells. Cytotoxic T-lymphocytes (CTLs) and natural killer cells mediate this process by releasing toxic proteins at the contact area with target cells known as immunological synapse (IS). Formation of a stable IS and exocytosis of toxic proteins requires persistent fusion of Rab11a recycling endosomes with the plasma membrane (PM) that may assure the delivery of key effector proteins. Despite the importance of the recycling endosomal compartment, the membrane fusion proteins that control this process at the IS remain elusive. Here, by performing knockdown experiments we found that syntaxin 4 (STX4) is necessary for cytotoxic activity and CD107a degranulation against target cells in a similar fashion to syntaxin 11, which is involved in lytic granule (LG) exocytosis and immunodeficiency when it is mutated. Using total internal reflection fluorescent microscopy we identified that STX4 mediates fusion of EGFPRab11a vesicles at the IS. Immunoprecipitation experiments in lysates of activated CTLs indicate that endogenous STX4 may drive this fusion step by interacting with cognate proteins:
| INTRODUCTION
Cytotoxic T-lymphocytes (CTLs) and natural killer (NK) cells play pivotal roles in host defense against viral infections and tumors.
1,2 They are responsible for killing target cells through the polarized exocytosis of cytolytic proteins such as perforin and granzymes that are contained in specialized lysosome-related organelles known as lytic granules (LGs). Recognition of foreign antigens on target cells through the T-cell receptor triggers signaling pathways that mediate the formation of a tight and well-defined structure at the interface of the 2 cells known as immunological synapse (IS). [3] [4] [5] Persistent signaling at the IS induces the maturation and polarization of LGs toward the IS where they finally fuse and release they cytolytic content. 6 Previous studies have shown that continual fusion of endosomal compartments with the plasma membrane (PM) is required to sustain signaling [7] [8] [9] and to focus LG exocytosis at the IS. 10, 11 However, the membrane trafficking machinery that controls these series of events is still poorly defined.
Several soluble-N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) have been associated to the cytotoxic pathway of CTL and NK cells. 6, 12 Studies in patients with defective cytotoxic activity have identified that the atypical lipid-anchored Syntaxin-11 (STX11) and its interacting Syntaxin Binding Protein 2 (STXBP2, also known as Munc18-2) are required for LG granule exocytosis. [13] [14] [15] Subjects harboring germline-mutations in these genes manifest with familial hemophagocytic lymphohisticytosis (F-HLH-4 and F-HLH-5, respectively), a life-threatening primary immunodeficiency that results in hyperinflammation because of an inability of the immune system to clear out viral infections or tumor cells. 16 Current evidences suggest that STX11 and Munc18-2 physically interact in multiple ways to drive the final fusion of the LG at the IS. [17] [18] [19] [20] On the other hand, recent studies propose that VAMP8-mediated fusion of Rab11a-positive recycling endosomes (Rab11a-RE) at the IS is essential for CTL killing activity. 10 These and other studies suggest that this process might be necessary for delivering key components to the PM, such as STX11 10 and signaling molecules 9 that are involved in the cytotoxic immune response.
Despite the importance of this membrane trafficking process, the precise SNAREs responsible for mediating fusion of Rab11a-RE at the PM are still elusive.
In this article, we found that Syntaxin 4 (STX4) is required for cytotoxic activity of human CTLs. Although, previous studies have
shown that STX4 is involved in GLUT4 transport and glucose homeostasis 21, 22 as well as antibody secretion, 23, 24 here, we describe a novel role of STX4 in meditating membrane fusion in the secretory pathway of CTLs. We found that treatment with small-interference Figure 1A,B) . To test the specificity of the siRNA treatments, we also evaluated the expression of other syntaxins or Munc18 proteins that are necessary for secretion of cytotoxic granules, 15 including Munc18-2 and Munc18-3. We did not observe a significant reduction in the expression of STX11, STX3, Munc18-2 and Munc18-3 in cells treated with different STX4 siRNAs (si-STX4-1 and si-STX4-2; Figure 1A ,B). Similarly, STX3 and STX11-siRNA treatment did not affect the expression of other tested relevant proteins. (Figure 1A,B) . We then tested the cytotoxic activity of these siRNA-treated cells by using a population-based redirected cell-killing assay against anti-CD3-coated P815 target cells. Percentage of target cell lysis was measured as amount of lactate dehydrogenase (LDH) enzyme released to the medium as described previously. 17 STX4 siRNA-treated cells exhibited over 60% reduction in target cell-killing activity compared with those treated with NTsiRNAs ( Figure 1C ). The reduction in cytotoxic activity of STX4 knockdown cells was comparable to the STX11 siRNA-treated cells, which were previously shown to have reduced killing activity because of impairment in LG exocytosis 15, 18, 20, 28 ( Figure 1C ). On the contrary, STX3 siRNA-treated cells, which also exhibited almost a 70% reduction in protein expression levels ( Figure 1D ), showed a slight increase in cytotoxic activity compared with NT siRNA-treated cells ( Figure 1C 
| STX4 knockdown inhibits degranulation of human CTLs
We next tested whether the reduced cytotoxic activity of cells treated with si-STX4-1 was due to an inability of LGs to fuse at the PM. To validate this, we used a flow cytometry-based "degranulation" and STX11 are required for the cytotoxic activity of CTLs, although they might act at different steps during the exocytosis of LGs.
| STX4 localizes at the PM of human CTLs
To better understand where STX4 works during the killing process we analyzed the subcellular localization of endogenous STX4 in both unconjugated and conjugated human CTL by using superresolution Stimulated Emission Depletion (STED) microscopy.
Images show that STX4 staining mainly gives a PM distribution pattern, which resembles and partially colocalizes with anti-CD3 staining, in both unconjugated and conjugated cells ( Figure 3A ).
We also observed a small fraction of STX4 within intracellular vesicles that did not significantly colocalize with anti-Vamp8, Rab11a
or perforin-containing vesicles as noted by the low Pearson's colocalization coefficient (PCC; Figure 3A dehydrogenase (LDH) released into the supernatant was quantified using a Cytotox-96 assay. Data are the mean AE SEM of 4 independent experiments run in quadruplicates. **P < .01; ***P < .001 
| STX4 interacts with the SM protein Munc18-3 but not with Munc18-2
To identify the membrane fusion machinery that co-operates with STX4 we first tested whether SM proteins expressed in human CTLs-Munc18-2 or Munc18-3
19
-interact with endogenous STX4.
We performed a series of co-IP experiments to pull-down endogenous Munc18-2, Munc18-3 and Cathepsin-S (as isotype antibody control) in lysates of primary human CTLs. In order to induce LG exocytosis, and thus stimulate SNARE complex formation, CTLs were previously activated with beads coated with anti-CD3/anti-CD28
antibodies and recombinant IL-2. Bound fractions were analyzed by western blot using antibodies against STX3, STX4 and STX11
( Figure 5A,B) . Interestingly, we found that Munc18-3 coimmunoprecipitated (co-IPed) with STX4 but not STX11 or STX3.
Conversely, Munc18-2 mainly interacts with STX11 and STX3 as it was previously reported. 13, 14, 17, 19 We did not detect any specific association between Munc18-2 and STX4 when compared with the control IP using Cathepsin-S antibodies ( Figure 5A,B) . Taken together, these results strongly indicate that STX4 and STX11 associate with different SM proteins to mediate distinct membrane fusion steps during cytotoxic immune response.
| Endogenous STX4 mainly interacts with SNAP23 and VAMP7/8 in primary human CTLs
To further elucidate the cognate SNAREs that contribute with STX4
for mediating Rab11a-RE fusion at the PM, we performed a series of co-IP experiments using anti-STX4, STX3 and IgG isotype control in lysates of human CTLs previously activated with CD3/CD28-coated beads. Bound fractions were analyzed by western blot using an array of antibodies against different SNAREs proteins ( Figure 6A ). Results showed that endogenous SNAP23, VAMP7 and VAMP8, but not VAMP4, preferentially co-IPed with STX4 when compared with STX3
and IgG IPs ( Figure 6B) . No VAMP2 or SNAP25 could be detected in the bound fraction either because they are not expressed in human CTLs, or they are below the detection limit as we previously described. 20 In summary, our results suggest that SNARE complexes consisting of STX4/SNAP23 and either VAMP7 or VAMP8 together with Munc18-3 might be responsible for driving Rab11a-RE fusion at the plasma for CTL-mediated killing process. associates with a specific set of trafficking proteins consisting of Munc18-3/SNAP23 and either Vamp7 or Vamp8, most probably to drive these fusion events.
| DISCUSSION
Fusion of Rab11a-RE at the IS is a critical step for normal CTL function. 7, 10, 36 Previous studies show that Rab11a is involved in actin remodeling and T-cell activation. 9 Specifically, Rab11a mediates recycling of receptors and effector proteins-such as Lck or components of the T-cell receptor-to sustain signaling and thus allow the formation of a stable IS. 7, 36 In addition, it has been proposed that Rab11a recycling at the IS delivers STX11 to the PM, 10, 18 which is necessary for later fusion of LGs. Our results are consistent with these studies and further demonstrate that STX4 is necessary for Rab11a-RE fusion at the IS and therefore for mediating the cytotoxic immune response.
We found that endogenous STX4 localizes at the PM of human CTLs as it was previously described in other cell-types, for example, pancreatic, adipose, epithelial, B-lymphocytes, mast cells and neurons. [30] [31] [32] [33] 37 In these cell types, STX4 mediates fusion at the PM and Giraudo Labs). Although further experiments are needed to investigate the correlation of these findings, they highlight the importance of STX4-mediated fusion of Rab11a-RE for CTLs.
| MATERIALS AND METHODS

| Antibodies
Mouse anti-human STX4, -CD3, -perforin and -Lamp1 were from BD Pharmingen. Rabbit anti-VAMP7 was from Novus Biologicals. Rabbit were from BD Biosciences.
| Cells and cell lines
Written consent was obtained from healthy donors for primary CD8 
| Co-IP assays
Primary human CD8 + cells previously activated with anti-CD3, anti-CD28 coated beads and recombinant IL-2 for 4 days were lysed (25 mM Tris, 150 mM NaCl, 1 mM EDTA, 5% (vol/vol) glycerol, 1%
(vol/vol) NP-40; pH 7.4) and centrifuged at 16,000 g for 15 minutes.
Co-IP experiments were carried out using a co-IP kit from Pierce 
| Degranulation assay
Degranulation of CD8+ T cells was measured by incubating cells in the presence or absence of target P815 cells and anti-CD3 antibody at a 1:1 ratio for 4 hours at 37 C as previously described. 17, 39, 40 Cells were labeled using anti-CD107a-PE, CD56-APC, CD8-FITC and CD3-PerCP.
CD3+ CD8+ CD56-cells were gated and assessed for surface expression of CD107a. Data were acquired using an Accuri-C6 flow cytometer (BD). Munc18-2 and Munc18-3 using lysates generated from healthy control CTLs activated with anti-CD3/anti-CD28 coated beads. Endogenous Munc18-2 or Munc18-3 were immunoprecipitated using goat antiMunc18-2, anti-Munc18-3 or anti-Cathepsin-S (Cath. S, as isotype control) antibodies and the amount of different CTL relevant Syntaxins; STX3, STX4 and STX11 that co-immunoprecipitated was analyzed by western blotting. B, Bands in the western blot that corresponded to the fraction of STXs that coprecipitated with Munc18-2, Munc18-3 or Cath. S were quantified by densitometry and normalized to the total amount of each protein present on the cell lysate used for the IPs. Results are representative of 3 independent experiments 2 Hamamatsu EM-charge-coupled device cameras and an environmental control system set to 5% CO 2 and 37 C. Fluorophores were excited with solid state 488 and 561 nm lasers, TIRF angle was set to 90 nm depth. Images were analyzed and processed using FIJI software. 41 Quantification of the Rab11a vesicles dwell-time was performed using the TracMate function of FIJI software.
